Outlook Therapeutics (OTLK) Net Margin (2015 - 2025)
Outlook Therapeutics (OTLK) reported Net Margin of 14482.19% for Q3 2025, up 1181.77% quarter-over-quarter from 1338.75% in Q2 2025.
Outlook Therapeutics (OTLK) Net Margin (2015 - 2025) Analysis & Trends
Outlook Therapeutics (OTLK) has 6 years of Net Margin data on file, last reported at 14482.19% in Q3 2025.
- Net Margin for Q3 2025 came in at 14482.19%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was 795.13% (changed N/A YoY), and the FY2025 annual result was 4416.22%, changed N/A from the prior year.
- Net Margin improved to 14482.19% in Q3 2025 per OTLK's latest filing, from 1338.75% in the prior quarter.
- Over five years, Net Margin peaked at 14482.19% in Q3 2025 and troughed at 1338.75% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.82% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 14,482.19% |
| Jun 30, 2025 | -1,338.75% |
| Sep 30, 2019 | -175.25% |
| Jun 30, 2019 | -787.71% |
| Mar 31, 2019 | -1,760.92% |
| Dec 31, 2018 | -926.60% |
| Sep 30, 2018 | -1,638.80% |
| Jun 30, 2018 | -1,176.92% |
| Mar 31, 2018 | -1,108.74% |
| Dec 31, 2017 | -2,296.48% |
| Sep 30, 2017 | -260.16% |
| Jun 30, 2017 | -1,758.72% |
| Mar 31, 2017 | -2,654.21% |
| Dec 31, 2016 | -6,300.21% |
| Sep 30, 2016 | -2,135.40% |
| Jun 30, 2016 | -6,101.20% |
| Mar 31, 2016 | -459.63% |
| Dec 31, 2015 | -1,789.51% |
| Sep 30, 2015 | -3,692.45% |
| Jun 30, 2015 | -960.06% |